Market Closed -
Sao Paulo
21:07:51 03/05/2024 BST
|
5-day change
|
1st Jan Change
|
4.69
BRL
|
-0.21%
|
|
+1.96%
|
-51.25%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
34,851
|
18,485
|
7,686
|
7,186
|
3,504
|
-
|
-
|
Enterprise Value (EV)
1 |
34,851
|
26,409
|
7,686
|
16,167
|
15,096
|
13,855
|
13,603
|
P/E ratio
|
-
|
-90.8
x
|
-19.8
x
|
-6.16
x
|
31.3
x
|
5.52
x
|
-
|
Yield
|
-
|
0.89%
|
-
|
-
|
0.64%
|
3.13%
|
-
|
Capitalization / Revenue
|
4.95
x
|
1.77
x
|
0.59
x
|
0.46
x
|
0.22
x
|
0.21
x
|
0.2
x
|
EV / Revenue
|
4.95
x
|
2.53
x
|
0.59
x
|
1.04
x
|
0.97
x
|
0.83
x
|
0.78
x
|
EV / EBITDA
|
-
|
20.6
x
|
3.54
x
|
6.91
x
|
5.42
x
|
4.44
x
|
3.97
x
|
EV / FCF
|
-
|
-7.23
x
|
-
|
-9.11
x
|
33.8
x
|
14.6
x
|
11.1
x
|
FCF Yield
|
-
|
-13.8%
|
-
|
-11%
|
2.96%
|
6.85%
|
9%
|
Price to Book
|
-
|
2.51
x
|
-
|
0.99
x
|
0.45
x
|
0.45
x
|
-
|
Nbr of stocks (in thousands)
|
480,705
|
547,872
|
559,827
|
746,960
|
747,048
|
-
|
-
|
Reference price
2 |
72.50
|
33.74
|
13.73
|
9.620
|
4.690
|
4.690
|
4.690
|
Announcement Date
|
07/03/21
|
28/03/22
|
28/03/23
|
28/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
7,039
|
10,419
|
13,129
|
15,557
|
15,587
|
16,628
|
17,519
|
EBITDA
1 |
-
|
1,282
|
2,168
|
2,339
|
2,785
|
3,124
|
3,427
|
EBIT
1 |
-
|
351.7
|
1,102
|
913.3
|
1,523
|
1,900
|
2,091
|
Operating Margin
|
-
|
3.38%
|
8.39%
|
5.87%
|
9.77%
|
11.43%
|
11.93%
|
Earnings before Tax (EBT)
1 |
-
|
-374.2
|
-578.8
|
-996
|
-86.51
|
582.5
|
332
|
Net income
1 |
-150.8
|
-226.6
|
-386.9
|
-1,130
|
4.381
|
475.3
|
478.2
|
Net margin
|
-2.14%
|
-2.17%
|
-2.95%
|
-7.26%
|
0.03%
|
2.86%
|
2.73%
|
EPS
2 |
-
|
-0.3715
|
-0.6932
|
-1.561
|
0.1500
|
0.8500
|
-
|
Free Cash Flow
1 |
-
|
-3,654
|
-
|
-1,775
|
447
|
949
|
1,224
|
FCF margin
|
-
|
-35.07%
|
-
|
-11.41%
|
2.87%
|
5.71%
|
6.99%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
16.05%
|
30.38%
|
35.72%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
10,203.43%
|
199.65%
|
255.93%
|
Dividend per Share
2 |
-
|
0.3012
|
-
|
-
|
0.0300
|
0.1467
|
-
|
Announcement Date
|
07/03/21
|
28/03/22
|
28/03/23
|
28/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
---|
Net sales
1 |
2,721
|
2,673
|
3,136
|
3,288
|
3,425
|
3,279
|
3,534
|
3,631
|
3,769
|
3,777
|
3,741
|
3,903
|
4,046
|
EBITDA
1 |
543.7
|
222.9
|
560.5
|
512.3
|
607.3
|
457.6
|
615.7
|
526.1
|
660.8
|
438
|
665.9
|
-
|
-
|
EBIT
1 |
299
|
-39.21
|
288.4
|
227.3
|
307.9
|
208
|
306
|
215.4
|
331
|
60.98
|
447.5
|
404.4
|
511.7
|
Operating Margin
|
10.99%
|
-1.47%
|
9.2%
|
6.91%
|
8.99%
|
6.34%
|
8.66%
|
5.93%
|
8.78%
|
1.61%
|
11.96%
|
10.36%
|
12.65%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
73.6
|
-167.1
|
37.11
|
-120.1
|
-89.36
|
-214.6
|
-166
|
-282.1
|
-180.5
|
-495
|
-30
|
-
|
-
|
Net margin
|
2.7%
|
-6.25%
|
1.18%
|
-3.65%
|
-2.61%
|
-6.54%
|
-4.7%
|
-7.77%
|
-4.79%
|
-13.11%
|
-0.8%
|
-
|
-
|
EPS
2 |
0.1281
|
-0.2630
|
0.0636
|
-0.2145
|
-0.1592
|
-0.3853
|
-0.3019
|
-0.3803
|
-
|
-
|
0.0500
|
0.0200
|
0.1100
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
12/11/21
|
28/03/22
|
12/05/22
|
11/08/22
|
14/11/22
|
28/03/23
|
12/05/23
|
10/08/23
|
09/11/23
|
28/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
7,924
|
-
|
8,981
|
11,592
|
10,352
|
10,099
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
6.183
x
|
-
|
3.84
x
|
4.162
x
|
3.314
x
|
2.947
x
|
Free Cash Flow
1 |
-
|
-3,654
|
-
|
-1,775
|
447
|
949
|
1,224
|
ROE (net income / shareholders' equity)
|
-
|
-4.09%
|
-
|
-16.2%
|
-4%
|
6.43%
|
8%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
13.50
|
-
|
9.740
|
10.50
|
10.50
|
-
|
Cash Flow per Share
2 |
-
|
2.320
|
-
|
-1.290
|
1.700
|
-
|
-
|
Capex
1 |
-
|
4,952
|
-
|
727
|
841
|
774
|
860
|
Capex / Sales
|
-
|
47.53%
|
-
|
4.67%
|
5.4%
|
4.65%
|
4.91%
|
Announcement Date
|
07/03/21
|
28/03/22
|
28/03/23
|
28/03/24
|
-
|
-
|
-
|
Last Close Price
4.69
BRL Average target price
9.556
BRL Spread / Average Target +103.74% Consensus |
1st Jan change
|
Capi.
|
---|
| -51.25% | 691M | | +13.70% | 81.4B | | -29.20% | 70.18B | | +9.72% | 29.08B | | -11.43% | 16.97B | | -0.43% | 16.96B | | -0.31% | 15.26B | | +3.42% | 12.41B | | -30.70% | 11.95B | | -6.75% | 11.93B |
Other Healthcare Facilities & Services
|